Navigation Links
Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
Date:2/14/2008

PITTSBURGH, Feb. 14 /PRNewswire-FirstCall/ -- In response to several inquiries, Mylan Inc. (NYSE: MYL) confirmed today that its matrix design Fentanyl Transdermal System (FTS) is not part of the widespread recall being conducted by Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ortho-McNeil reported that all lots of 25 mcg/hr Duragesic(R) CII patches sold by PriCara in the United States and all 25 mcg/hr Fentanyl patches sold by Sandoz Inc. in the United States are being voluntarily recalled as a precaution from wholesalers and pharmacies because they may have a cut along one side of the drug reservoir within the patch. The result is possible release of Fentanyl gel from the gel reservoir into the pouch in which the patch is packaged, exposing patients or caregivers directly to Fentanyl gel.

Unlike all other U.S. marketed Fentanyl patches, Mylan's FTS is a matrix patch, not a reservoir patch, and therefore does not leak.

Mylan Vice Chairman and CEO Robert J. Coury commented: "We have always believed that our Fentanyl Transdermal System is differentiated from all other Fentanyl patches in the U.S. market because of its unique matrix design. This is an important product characteristic that should be recognized and understood when choosing a Fentanyl Transdermal System."

Mylan's FTS was the first generic Class II narcotic transdermal product approved by the U.S. Food and Drug Administration.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matr
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Restores Availability of Generic Levothyroxine in Florida
2. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
3. Mylan Declares Quarterly Preferred Stock Dividend
4. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
5. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
6. Mylan Sets Date of 2008 Annual Meeting
7. Mylan Receives $26.2 Million From Exercise of Overallotment Option of Common Stock
8. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
9. Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock
10. Mylan Prices Offerings of Common Stock and Mandatory Convertible Preferred Stock
11. Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Absolute PhysioCare and Sports Rehab, ... of its custom orthotics and gait scan analysis that ... in order to restore normal body balance. This treatment ... fatigue and pain. In addition, Custom orthotics provides shock ... foot, resulting in relief and greater comfort while walking, ...
(Date:7/23/2014)... 2014 Adipic acid is an ... a high-performance plastic, often referred to as engineering ... depending on the monomers employed. Due to the ... and the increasing number of developing countries, the ... share, followed by Europe and North America. Adipic ...
(Date:7/23/2014)... -- For critically ill patients arriving at the ... analgesia, sedation and amnesia for rapid, life-saving intubation, ... pressure. The results of a systematic review ... physicians regard as a "wonder drug" are published ... " The Effect of Ketamine on Intracranial and ...
(Date:7/23/2014)... RFcnn.com, a distinguished electrical equipment retailer, has ... . What’s more, the company has decided to provide big ... who place an order for the company’s brand new SMA ... , The high quality SMA JACK from RFcnn.com Provides ... superb quality electrical equipment to help make things much easier ...
(Date:7/23/2014)... workplaces may need to consider innovative methods to prevent ... on results from a new study published in the ... JOEH ), workers who are obese may have significantly ... their non-obese counterparts. , The study, conducted at ... 32 individuals in four categories (non-obese young, obese young, ...
Breaking Medicine News(10 mins):Health News:Custom Orthotics at Burnaby PhysioCare Now Correct Foot Abnormalities 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Adipic Acid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Ketamine can be a wonder drug for ER patients and their physicians 2Health News:New Collection of SMA JACK Released by China Electrical Accessory Manufacturer RFcnn 2Health News:Obesity linked to low endurance, increased fatigue in the workplace 2
... clues to effects of aging, experts say , , THURSDAY, ... an important role in coordinating people,s circadian clocks and ... The circadian clock governs daily cycles of feeding, activity ... the Washington University School of Medicine said their finding ...
... more control of their high blood pressure (hypertension) when ... Dr. Ross D. Feldman, a clinical scientist with the ... recommends a simplified and more effective method of treating ... than multiple pills. The "Simplified Treatment Intervention to ...
... company cofounded by Beth Israel Deaconess Medical Center (BIDMC) ... has announced that it has closed an $8M Series ... Life Sciences (SVLS) and MedImmune Ventures. , The company ... T-cells, with their first program focusing on treatments for ...
... with the computer age comes the age of eye fatigue. ... at work or leisure), we develop a host of symptoms and ... ... sound familiar? Well, you are not alone. You ... The good news is that relief may be within your reach ...
... to Creating Realistic Development TimelinesRALEIGH, N.C., March 19 ... announces its Senior Vice President of Scientific and Medical ... site and country selection. The webinar will take place ... Thoelke will discuss how to mitigate one of the ...
... 19 The "Help is Here Express" bus tour ... 23-27 at various cities throughout the state in order ... programs that provide prescription medicines for free or nearly ... nine straight months, and having passed the national unemployment ...
Cached Medicine News:Health News:Internal Clock and Metabolism May Be Linked 2Health News:Biotech company cofounded by BIDMC scientists targets natural killer T-cells 2Health News:The Power of a Tiny Microscopic Plant Found To Reduce Computer Eye Strain 2Health News:PRA International Speaking Event: Beyond Global Feasibility 2Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 4
(Date:7/23/2014)... MINNEAPOLIS , July 23, 2014 ... they have added 14 new vendors so far ... Creekridge,s newest vendors are from both ... mid-size domestic organizations to large, well-known multi-national companies. ... Creekridge,s diversified suite of financing products including: standard ...
(Date:7/23/2014)... South Korea , July 23, 2014  Mezzion ... clinical program to evaluate the use of udenafil to ... for single ventricle heart defects. The clinical program will ... representatives of the Pediatric Heart Network (PHN), a multi-center ... and Blood Institute (NHLBI) of the National Institutes of ...
(Date:7/23/2014)... LONDON , July 23, 2014  Lightlake ... developing addiction treatments based on its expertise in ... an investigational new drug application ("IND") with respect ... Lightlake also announced today that it has received ... Drug Abuse ("NIDA"), part of the National Institutes ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: